The expression of PAX5 was significantly down-regulated in breast cancer tissues, while the expression levels of DNMT1 and ZEB1 were both up-regulated in breast cancer tissues, compared with normal tissues (Fig. 6A). Here, PAX5 is linked to breast carcinoma.